Key result
PKP2 gene replacement restores contractility and desmosome assembly in plakophilin-2-deficient cardiomyocytes.
Why the study?
Loss-of-function mutations in PKP2 cause arrhythmogenic cardiomyopathy, and a human model recapitulating disease pathology is needed for gene replacement therapy development.
Does Adeno-associated virus-mediated gene replacement of PKP2 improve contractility and desmosome assembly in iPSC-CMs from a patient with arrhythmogenic cardiomyopathy?
Does Adeno-associated virus-mediated gene replacement of PKP2 improve contractility and desmosome assembly in iPSC-CMs from a patient with arrhythmogenic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
AAV-mediated PKP2 gene replacement restores contractility and desmosome assembly in an iPSC-CM model of arrhythmogenic cardiomyopathy, providing proof-of-concept for gene therapy.
Loss-of-function mutations in PKP2, which encodes plakophilin-2, cause arrhythmogenic cardiomyopathy (AC). Restoration of deficient molecules can serve as upstream therapy, thereby requiring a human model that recapitulates disease pathology and provides distinct readouts in phenotypic analysis for proof of concept for gene replacement therapy. Here, we generated isogenic induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) with precisely adjusted expression of plakophilin-2 from a patient with AC carrying a heterozygous frameshift PKP2 mutation. After monolayer differentiation, plakophilin-2 deficiency led to reduced contractility, disrupted intercalated disc structures, and impaired desmosome assembly in iPSC-CMs. Allele-specific fluorescent labeling of endogenous DSG2 encoding desmoglein-2 in the generated isogenic lines enabled real-time desmosome-imaging under an adjusted dose of plakophilin-2. Adeno-associated virus-mediated gene replacement of PKP2 recovered contractility and restored desmosome assembly, which was sequentially captured by desmosome-imaging in plakophilin-2-deficient iPSC-CMs. Our isogenic set of iPSC-CMs recapitulates AC pathology and provides a rapid and convenient cellular platform for therapeutic development.
No takes yet. Share an insight, caveat, or question.
Inoue et al. (2022) studied Plakophilin-2 deficiency. Plakophilin-2 deficiency in isogenic iPS cell-derived cardiomyocytes was evaluated. Plakophilin-2 deficiency in isogenic iPS cell-derived cardiomyocytes models reduced contractility and impaired desmosome assembly.
Synapse has enriched 10 related papers. Consider them for comparative context: